JP2023515687A5 - - Google Patents
Info
- Publication number
- JP2023515687A5 JP2023515687A5 JP2022552626A JP2022552626A JP2023515687A5 JP 2023515687 A5 JP2023515687 A5 JP 2023515687A5 JP 2022552626 A JP2022552626 A JP 2022552626A JP 2022552626 A JP2022552626 A JP 2022552626A JP 2023515687 A5 JP2023515687 A5 JP 2023515687A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- met
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062984159P | 2020-03-02 | 2020-03-02 | |
| US62/984,159 | 2020-03-02 | ||
| PCT/US2021/020255 WO2021178296A1 (en) | 2020-03-02 | 2021-03-01 | Therapeutic uses of macrocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515687A JP2023515687A (ja) | 2023-04-13 |
| JP2023515687A5 true JP2023515687A5 (https=) | 2024-03-07 |
Family
ID=77613771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552626A Pending JP2023515687A (ja) | 2020-03-02 | 2021-03-01 | 大環状化合物の治療使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250262216A1 (https=) |
| EP (1) | EP4114530A4 (https=) |
| JP (1) | JP2023515687A (https=) |
| KR (1) | KR20230022151A (https=) |
| CN (1) | CN115397514A (https=) |
| AU (1) | AU2021229457A1 (https=) |
| BR (1) | BR112022017425A2 (https=) |
| CA (1) | CA3174455A1 (https=) |
| IL (1) | IL295938A (https=) |
| MX (1) | MX2022010945A (https=) |
| WO (1) | WO2021178296A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111902417B (zh) | 2018-04-25 | 2023-07-28 | 北京普祺医药科技股份有限公司 | 一种二芳基巨环化合物、药物组合物以及其用途 |
| US20240132517A1 (en) * | 2021-02-10 | 2024-04-25 | Goharmony Therapeutics (Shenzhen) Co., Ltd. | Macrocyclic compound, pharmaceutical composition, and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS49779B (sr) * | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| ES2933350T3 (es) * | 2014-01-24 | 2023-02-06 | Turning Point Therapeutics Inc | Macrociclos de diarilo como moduladores de proteína quinasas |
| RU2765181C2 (ru) * | 2015-07-06 | 2022-01-26 | Тёрнинг Поинт Терапьютикс, Инк. | Полиморфная форма диарильного макроцикла |
| US10689400B2 (en) * | 2016-07-28 | 2020-06-23 | Turning Point Therapeutics, Inc. | Macrocycle kinase inhibitors |
| CN111182903A (zh) * | 2017-07-28 | 2020-05-19 | 特普医药公司 | 巨环化合物及其用途 |
| CN114423762B (zh) * | 2019-09-30 | 2024-03-29 | 浙江海正药业股份有限公司 | 大环类衍生物及其制备方法和用途 |
-
2021
- 2021-03-01 EP EP21764224.8A patent/EP4114530A4/en not_active Withdrawn
- 2021-03-01 JP JP2022552626A patent/JP2023515687A/ja active Pending
- 2021-03-01 CN CN202180023879.XA patent/CN115397514A/zh active Pending
- 2021-03-01 CA CA3174455A patent/CA3174455A1/en active Pending
- 2021-03-01 BR BR112022017425A patent/BR112022017425A2/pt unknown
- 2021-03-01 WO PCT/US2021/020255 patent/WO2021178296A1/en not_active Ceased
- 2021-03-01 MX MX2022010945A patent/MX2022010945A/es unknown
- 2021-03-01 KR KR1020227034099A patent/KR20230022151A/ko active Pending
- 2021-03-01 IL IL295938A patent/IL295938A/en unknown
- 2021-03-01 AU AU2021229457A patent/AU2021229457A1/en not_active Abandoned
- 2021-03-01 US US17/905,503 patent/US20250262216A1/en active Pending